Infecciones por virus respiratorio sincitial. Antiguos retos y nuevas estrategias
Authors:
- O. RamiloORO. Ramilo
- A. MejíasAMA. Mejías
- 1 July 2008
- journal article
- editorial
- Published by Elsevier in Anales de Pediatría
- Vol. 69 (1) , 1-4
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Palivizumab Use in Subjects with Congenital Heart DiseasePediatric Cardiology, 2007
- The Association Between Respiratory Syncytial Virus Infection and the Development of Childhood AsthmaThe Pediatric Infectious Disease Journal, 2007
- Respiratory syncytial virus pneumonia: mechanisms of inflammation and prolonged airway hyperresponsivenessCurrent Opinion in Infectious Diseases, 2005
- Severe Respiratory Syncytial Virus Bronchiolitis in Infancy and Asthma and Allergy at Age 13American Journal of Respiratory and Critical Care Medicine, 2005
- Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart diseaseThe Journal of Pediatrics, 2003
- Bronchiolitis-Associated Hospitalizations Among US Children, 1980-1996JAMA, 1999
- Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 yearsThe Lancet, 1999
- Palivizumab, a Humanized Respiratory Syncytial Virus Monoclonal Antibody, Reduces Hospitalization From Respiratory Syncytial Virus Infection in High-risk InfantsPediatrics, 1998
- Prophylactic Administration of Respiratory Syncytial Virus Immune Globulin to High-Risk Infants and Young ChildrenNew England Journal of Medicine, 1993
- RESPIRATORY SYNCYTIAL VIRUS DISEASE IN INFANTS DESPITE PRIOR ADMINISTRATION OF ANTIGENIC INACTIVATED VACCINE12American Journal of Epidemiology, 1969